Maruf Ahmed Bhuiyan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maruf Ahmed Bhuiyan has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Abdulazeez Giwa
Department of Zoology and Environmental Biology, Lagos State University, Lagos, Nigeria
1 shared publication - Abdus Samad
Graduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin, Republic of Korea
1 shared publication - Abisogun Mujib Olamilekan
Department of Cell Biology and Genetics (Genetics), University of Lagos, Lagos Nigeria.
1 shared publication - Afsana Anwar Miti1 shared publication
- Afzalun Nessa
Professor, Department of Virology, Bangladesh Medical University
1 shared publication - Ayesha Alam Mita
Medical Officer, Department of Virology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 10 July 2025
- Published by Bangladesh Academy of Sciences in Bangabandhu Sheikh Mujib Medical University Journal
- Vol. 18 (3) , e83258
Association of climate variability with hepatitis A and E infections in Dhaka (2016–2023)
Background: Acute viral hepatitis, predominantly caused by hepatitis A virus (HAV) and hepatitis E virus (HEV), remains a major global public health issue, especially in low- and middle-income countries. This study was conducted to determine the prevalence of acute hepatitis A and E infections in Dhaka city and to examine the influence of weather conditions on their transmission. Methods: This retrospective study, based on laboratory data, was conducted at the Department of Virology, Bangladesh Medical University from 2016 to 2023. It analysed the test results for anti-HAV-IgM and anti-HEV-IgM antibodies from blood specimens of suspected acute hepatitis cases. The patients’ details and laboratory results were retrieved using the Laboratory Information System, and climatic variables (temperature, humidity, and rainfall) were obtained from the Bangladesh Meteorological Department. Results: In this study, test reports from 19,542 individuals for HAV and 23,249 individuals for HEV were analysed. HAV was detected in 29.5% of the population, and HEV was found in 20.6%. Males were predominantly seropositive for both HAV (65.1%) and HEV (76%). HAV was most common in those aged ≤10 and 11–20 years (37.9%), whereas HEV was most common in the 21–30 years group (40.6%). Higher HAV transmission was observed during autumn and late autumn, while HEV was more prevalent in summer and the rainy season. Conclusion: Acute HAV and HEV infections are common in Dhaka city, and climatic factors affect their spread. Understanding these patterns can improve public health readiness and raise awareness of social health hygiene.
- 10 July 2025
- Published by Bangladesh Academy of Sciences in Bangabandhu Sheikh Mujib Medical University Journal
- Vol. 18 (3) , e83258
Open AccessAssociation of climate variability with hepatitis A and E infections in Dhaka (2016–2023)
Background: Acute viral hepatitis, predominantly caused by hepatitis A virus (HAV) and hepatitis E virus (HEV), remains a major global public health issue, especially in low- and middle-income countries. This study was conducted to determine the prevalence of acute hepatitis A and E infections in Dhaka city and to examine the influence of weather conditions on their transmission. Methods: This retrospective study, based on laboratory data, was conducted at the Department of Virology, Bangladesh Medical University from 2016 to 2023. It analysed the test results for anti-HAV-IgM and anti-HEV-IgM antibodies from blood specimens of suspected acute hepatitis cases. The patients’ details and laboratory results were retrieved using the Laboratory Information System, and climatic variables (temperature, humidity, and rainfall) were obtained from the Bangladesh Meteorological Department. Results: In this study, test reports from 19,542 individuals for HAV and 23,249 individuals for HEV were analysed. HAV was detected in 29.5% of the population, and HEV was found in 20.6%. Males were predominantly seropositive for both HAV (65.1%) and HEV (76%). HAV was most common in those aged ≤10 and 11–20 years (37.9%), whereas HEV was most common in the 21–30 years group (40.6%). Higher HAV transmission was observed during autumn and late autumn, while HEV was more prevalent in summer and the rainy season. Conclusion: Acute HAV and HEV infections are common in Dhaka city, and climatic factors affect their spread. Understanding these patterns can improve public health readiness and raise awareness of social health hygiene.
- Open Access
Transcriptomic dysregulations associated with SARS-CoV-2 infection in human nasopharyngeal and peripheral blood mononuclear cells
Introduction: Over 24 million people have been infected globally with the novel coronavirus, SARS-CoV-2, with more than 820,000 succumbing to the resulting COVID-19 disease as of the end of August 2020. The molecular mechanisms underlying the pathogenesis of the disease are not completely elucidated. Thus, we aim to understand host response to SARS-CoV-2 infection by comparing samples collected from two distinct compartments (infection site and blood), obtained from COVID-19 subjects and healthy controls. Methods: We used two publicly available gene expression datasets generated via RNA sequencing in two different samples; nasopharyngeal swabs and peripheral blood mononuclear cells (PBMCs). We performed a differential gene expression analysis between COVID-19 subjects and healthy controls in the two datasets and then functionally profiled their differentially expressed genes (DEGs). The genes involved in innate immunity were also determined. Results: We found a clear difference in the host response to SARS-CoV-2 infection between the two sample groups. In COVID-19 subjects, the nasopharyngeal sample group indicated upregulation of genes involved in cytokine activity and interferon signalling pathway, as well as downregulation of genes involved in oxidative phosphorylation and viral transcription. Host response in COVID-19 subjects for the PBMC group, involved upregulation of genes involved in the complement system and immunoglobulin mediated immune response. CXCL13, GABRE, IFITM3 were upregulated and HSPA1B was downregulated in COVID-19 subjects in both sample groups. Conclusion: Our results indicate the host response to SARS-CoV-2 is compartmentalized and suggests potential biomarkers of response to SARS-CoV-2 infection. Highlights: Transcriptomic profiling from publicly available RNA-seq count data revealed a site-specific immune response in COVID-19. Host response was found cellular-mediated in nasopharyngeal samples and humoral-mediated in PBMCs samples. CXCL13, GABRE and IFITM3 commonly upregulated and HSPA1B downregulated in both sample groups highlights the potential of these molecules as markers of response to SARS-CoV-2 infection.
Open AccessTranscriptomic dysregulations associated with SARS-CoV-2 infection in human nasopharyngeal and peripheral blood mononuclear cells
Introduction: Over 24 million people have been infected globally with the novel coronavirus, SARS-CoV-2, with more than 820,000 succumbing to the resulting COVID-19 disease as of the end of August 2020. The molecular mechanisms underlying the pathogenesis of the disease are not completely elucidated. Thus, we aim to understand host response to SARS-CoV-2 infection by comparing samples collected from two distinct compartments (infection site and blood), obtained from COVID-19 subjects and healthy controls. Methods: We used two publicly available gene expression datasets generated via RNA sequencing in two different samples; nasopharyngeal swabs and peripheral blood mononuclear cells (PBMCs). We performed a differential gene expression analysis between COVID-19 subjects and healthy controls in the two datasets and then functionally profiled their differentially expressed genes (DEGs). The genes involved in innate immunity were also determined. Results: We found a clear difference in the host response to SARS-CoV-2 infection between the two sample groups. In COVID-19 subjects, the nasopharyngeal sample group indicated upregulation of genes involved in cytokine activity and interferon signalling pathway, as well as downregulation of genes involved in oxidative phosphorylation and viral transcription. Host response in COVID-19 subjects for the PBMC group, involved upregulation of genes involved in the complement system and immunoglobulin mediated immune response. CXCL13, GABRE, IFITM3 were upregulated and HSPA1B was downregulated in COVID-19 subjects in both sample groups. Conclusion: Our results indicate the host response to SARS-CoV-2 is compartmentalized and suggests potential biomarkers of response to SARS-CoV-2 infection. Highlights: Transcriptomic profiling from publicly available RNA-seq count data revealed a site-specific immune response in COVID-19. Host response was found cellular-mediated in nasopharyngeal samples and humoral-mediated in PBMCs samples. CXCL13, GABRE and IFITM3 commonly upregulated and HSPA1B downregulated in both sample groups highlights the potential of these molecules as markers of response to SARS-CoV-2 infection.
- Open Access
- 18 August 2020
- Published by F1000 Research Ltd in F1000Research
- Vol. 9, 999
Discovery of potential immune epitopes and peptide vaccine design - a prophylactic strategy against Rift Valley fever virus
Background: Rift Valley fever virus (RVFV) is an emerging arbovirus infecting both animals and humans. Any form of direct contact with body fluids, blood or tissue of infected animals is the mode of transmission of this pathogen. Despite being an emerging virus, no proper vaccinations are yet available for the public. Our objective is to compose a multiepitope vaccine utilizing immuno-bioinformatics as a strategy against RVFV. Methods: To identify immunodominant epitopes and design a potent vaccine candidate, we applied a series of immunoinformatic approaches with molecular dynamics and immune response simulation frameworks. Results: A glycoprotein with the highest antigenicity was selected and employed for determining promising epitopes. We selected T cell epitopes based on their immunological potencies and cytokine inducing properties, while B cell epitopes were selected based on their antigenic features. Finally, we selected four cytotoxic T-lymphocyte, two helper T-lymphocyte, and three linear B-lymphocyte epitopes that were arranged into a vaccine construct with appropriate adjuvants and linkers. The chimera protein was modeled, refined, and validated prior to docking against toll-like receptor 4. Docking studies suggest strong binding interactions while dynamics simulation revealed the stable nature of the docked complex. Furthermore, the immune simulation showed robust and prolonged immune responses with rapid antigen clearance. Finally, codon optimization and cloning conducted with Escherichia coli K12 suggests high translation efficiency within the host system. Conclusion: We believe that our designed multiepitope vaccine is a promising prophylactic candidate against RVFV pathogenesis.
- 18 August 2020
- Published by F1000 Research Ltd in F1000Research
- Vol. 9, 999
Open AccessDiscovery of potential immune epitopes and peptide vaccine design - a prophylactic strategy against Rift Valley fever virus
Background: Rift Valley fever virus (RVFV) is an emerging arbovirus infecting both animals and humans. Any form of direct contact with body fluids, blood or tissue of infected animals is the mode of transmission of this pathogen. Despite being an emerging virus, no proper vaccinations are yet available for the public. Our objective is to compose a multiepitope vaccine utilizing immuno-bioinformatics as a strategy against RVFV. Methods: To identify immunodominant epitopes and design a potent vaccine candidate, we applied a series of immunoinformatic approaches with molecular dynamics and immune response simulation frameworks. Results: A glycoprotein with the highest antigenicity was selected and employed for determining promising epitopes. We selected T cell epitopes based on their immunological potencies and cytokine inducing properties, while B cell epitopes were selected based on their antigenic features. Finally, we selected four cytotoxic T-lymphocyte, two helper T-lymphocyte, and three linear B-lymphocyte epitopes that were arranged into a vaccine construct with appropriate adjuvants and linkers. The chimera protein was modeled, refined, and validated prior to docking against toll-like receptor 4. Docking studies suggest strong binding interactions while dynamics simulation revealed the stable nature of the docked complex. Furthermore, the immune simulation showed robust and prolonged immune responses with rapid antigen clearance. Finally, codon optimization and cloning conducted with Escherichia coli K12 suggests high translation efficiency within the host system. Conclusion: We believe that our designed multiepitope vaccine is a promising prophylactic candidate against RVFV pathogenesis.